One mechanism used by teleost fishes to produce acoustic communication signals involves the contraction of sonic "drum" muscles that appose the lateral walls of the swimbladder. In one marine species, the midshipman (Porichthys notatus), there is a sex difference in the overall size of the swimbladder as well as in the ultrastructural properties of its myofibrils. Additionally, there are two classes of sexually mature males referred to as Type I and Type II. The peripheral sonic motor system of Type I males differs from that of Type II males and females (which resemble each other) in a number of ways: (1) the mass of their swimbladder and associated sonic muscles is 50% greater, (2) their muscle fibers are several times larger and have a characteristically large volume of sarcoplasm that surrounds the myofibrils and is densely filled with mitochondria, (3) the length of z-lines of their myofibrils is about 20-fold greater, and (4) their sarcoplasmic reticulum is more highly branched. The ultrastructure of the myofibrils of Type II males and females resembles that found in the sonic muscle of males and females in other related species. The larger mass and specializations of the sonic muscle in Type I males are considered to be adaptations related to their known role in sound production and the unique long duration "humming" sounds that they generate during the breeding season. The similarity in the sonic motor system between females and Type II males is considered to be related to the utilization of an "alternative mating strategy" by Type II males. To our knowledge, this is the first documentation of a sex difference or, for that matter, a sexual polymorphism in the ultrastructural features of a vertebrate myofibril.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/cne.902860202 | DOI Listing |
J Pediatr Orthop B
March 2025
Biostatistics, Ankara University Faculty of Medicine, Ankara, Turkey.
Pediatric hand traumas are common injuries in childhood. The incidence and type of injury vary with age. In our country, there are only two publications in which only crush is examined in etiology.
View Article and Find Full Text PDFFront Public Health
January 2025
China Institute of Regulation Research, Zhejiang University of Finance and Economics, Hangzhou, China.
Introduction: Relaxing entry regulation for private hospitals and fostering competition in the healthcare market are crucial prerequisites for addressing the diverse healthcare demands of the population and promoting the development of a Healthy China. This study aims to comprehensively evaluate the health effect of relaxing entry regulation for private hospitals and to examine its nonlinear characteristics.
Methods: Using panel data from 31 provinces in mainland China, this study employs a fixed effects panel data model to investigate the health effect of relaxing entry regulation for private hospitals.
J Anus Rectum Colon
January 2025
Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
Objectives: Effective treatments for diarrhea-type irritable bowel syndrome (IBS-D) are limited. Hangeshashinto (HST), an anti-inflammatory Kampo medicine, may offer benefits but its efficacy for IBS-D requires further investigation. This study evaluated IBS-D symptom improvement and gut microbiota changes following HST administration.
View Article and Find Full Text PDFCureus
January 2025
Adult Critical Care, St George's University Hospitals NHS Foundation Trust, London, GBR.
Anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitides are a group of rare diseases that cause inflammation of small to medium vessels. They comprise granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA). As the signs and symptoms are varied, the diagnosis of vasculitis is complex and challenging; however, there are type-specific clinical presentations that can be factored into the existing classification criteria.
View Article and Find Full Text PDFKidney Med
February 2025
Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pure red cell aplasia (PRCA) is a rare complication of erythropoietin (EPO) therapy, characterized by a severe deficiency in red blood cell production. There is no guideline on the treatment for PRCA because there have been too few cases to perform prospective cohort studies. The main treatments for PRCA include immediate cessation of EPO, restrictive transfusion, and immunosuppressive therapies.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!